Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioAtla (BCAB) Return on Capital Employed (2021 - 2025)

BioAtla (BCAB) has 5 years of Return on Capital Employed data on record, last reported at 18.76% in Q3 2025.

  • For Q3 2025, Return on Capital Employed fell 1688.0% year-over-year to 18.76%; the TTM value through Sep 2025 reached 18.76%, down 1688.0%, while the annual FY2024 figure was 1.03%, 14.0% down from the prior year.
  • Return on Capital Employed reached 18.76% in Q3 2025 per BCAB's latest filing, down from 3.96% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.23% in Q1 2021 and bottomed at 18.76% in Q3 2025.
  • Average Return on Capital Employed over 5 years is 2.05%, with a median of 0.76% recorded in 2023.
  • Peak YoY movement for Return on Capital Employed: fell -12bps in 2022, then crashed -1688bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.39% in 2021, then tumbled by -50bps to 0.59% in 2022, then plummeted by -106bps to 1.21% in 2023, then tumbled by -43bps to 1.73% in 2024, then plummeted by -985bps to 18.76% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 18.76% in Q3 2025, 3.96% in Q2 2025, and 2.29% in Q1 2025.